Author:
Ruscica Massimiliano,Zimetti Francesca,Adorni Maria Pia,Sirtori Cesare R.,Lupo Maria Giovanna,Ferri Nicola
Reference150 articles.
1. Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics;Boden;Eur. Heart J.,2019
2. A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies;Tsimikas;J. Am. Coll. Cardiol.,2017
3. Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease;Elshazly;Eur. J. Prev. Cardiol.,2019
4. The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk;Sandesara;Endocr. Rev.,2019
5. Present therapeutic role of cholesteryl ester transfer protein inhibitors;Ferri;Pharmacol. Res.,2018
Cited by
64 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献